- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01566929
Weight Management Intervention for Obese Women and the Live Birth Outcome of in Vitro Fertilization (IVF)
5. september 2018 oppdatert av: Ann Thurin Kjellberg, Sahlgrenska University Hospital, Sweden
Weight Management Interventions for Obese Women and the Live Birth Outcome of in Vitro Fertilization (IVF): a Randomized Controlled Trial
The primary aim of the study is to evaluate if weight management intervention for obese women (BMI≥30<35 kg/m2) prior to IVF improves the outcome assessed as live birth per participating woman, as compared to women where no intervention was made.
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
There will be two groups of patients.
- The first group (n=167) will receive weight management intervention during up to four months prior to IVF treatment.The group randomized to intervention will start an intensive weight reduction plan. The aim of the weight reduction is to reach as close to normal BMI (<25.0 kg/m2) as possible during a time of approximately 4 months. The purpose of the dietary intervention is to create a negative energy balance to induce weight loss. The intervention starts with 12 weeks of a low calorie liquid formula diet (LCD) and thereafter, diet re-introduction and weight control stabilization until IVF treatment begins. Should the patient for some reason be unable to fulfil the LCD-treatment, she will anyhow have an individualized dietary counselling to help her loose weight until the time for her IVF-treatment.
- The second group (n=167) will start their IVF-treatment directly without other intervention than written advice about the benefits of weight reduction and exercise. The group randomized directly to IVF-treatment will start the treatment as soon as possible after randomization, preferably within that menstrual cycle.
- Tertiary aim is a follow-up 2 years after randomization to the study with questionnaires to the couple in both the intervention and the control groups. A special questionnaire will cover the weights of the couple and if the woman has had any pregnancies or live births after concluding the study. For the women having achieved a live birth in the index-cycle of IVF the number of children and also follow-up of the children will be performed by assessing medical records from pediatric clinic (if applicable) and child health care centres covering birth data, general health and weight of the children at birth and at the assessment date. Eating -habits and -patterns and quality of life parameters will be assessed with the same three questionnaires that were filled in after randomization.
Studietype
Intervensjonell
Registrering (Faktiske)
317
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
-
Copenhagen, Danmark
- Rigshospitalet
-
Copenhagen, Danmark
- Herlev Hospital
-
Copenhagen, Danmark
- Hvidovre Hospital
-
Holbaek, Danmark
- Holbaek Hospital
-
-
-
-
-
Reykjavik, Island
- ART Medica
-
-
-
-
-
Göteborg, Sverige
- Sahlgrenska University Hospital
-
Malmö, Sverige
- Skånes universitetssjukhus
-
Stockholm, Sverige
- Karolinska Universitetssjukhuset
-
Örebro, Sverige
- Örebro University Hospital
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
18 år til 37 år (Voksen)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Hunn
Beskrivelse
Inclusion criteria
- Indication for IVF/ICSI for the couple
- Woman's age >18< 38 years at randomization
- First, second or third IVF/ICSI treatment
- BMI > or = 30.0 <35.0 kg/m2
- Willing to participate and to sign informed consent
Exclusion Criteria:
- Diabetes mellitus treated with insulin
- Oocyte or sperm donation planned
- Preimplantation genetic diagnosis (PGD) treatment planned
- Azoospermia known at randomization
- Patient not having adequate knowledge of Swedish (to understand patient information and questionnaires)
- QEWP-R questionnaire indicating binge eating disorder for the woman
- Previous participation in the study
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Ingen inngripen: IVF only
IVFtreatment
|
|
Aktiv komparator: Weight reduction treatment and IVF
Dietary Supplement: Low calorie diet treatment and then IVFtreatment
|
Reduction of calorie intake to only 800 kcal/day by using LCD during 12 weeks
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Live birth
Tidsramme: Approximately 10-16 months after randomization, depending on study group.
|
Live birth per participating woman
|
Approximately 10-16 months after randomization, depending on study group.
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
embryology
Tidsramme: After theIVF-treatment, approximately 1-6 months after randomization
|
number of good quality embryos
|
After theIVF-treatment, approximately 1-6 months after randomization
|
obstetric outcomes
Tidsramme: Approximately 10-16 months after randomization, after delivery
|
obstetric and neonatal data
|
Approximately 10-16 months after randomization, after delivery
|
compliance to intervention
Tidsramme: Assessed in the intervention group 12-16 weeks after randomization, prior to IVF-treatment
|
Compliance to intervention assessed as weight loss during intervention, dietary intake and quality of life
|
Assessed in the intervention group 12-16 weeks after randomization, prior to IVF-treatment
|
Husband data
Tidsramme: before IVF-treatment
|
Measurement of the husband for height, weight and dietary intake and eating patterns correlated to sperm count, sperm motility and sperm chromatin fragmentation
|
before IVF-treatment
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Ann Thurin Kjellberg, MD PhD, Sahlgrenska University Hospital, Sweden
Publikasjoner og nyttige lenker
Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.
Generelle publikasjoner
- Svensson H, Einarsson S, Olausson D, Kluge L, Bergh C, Eden S, Lonn M, Thurin-Kjellberg A. Inflammatory and metabolic markers in relation to outcome of in vitro fertilization in a cohort of predominantly overweight and obese women. Sci Rep. 2022 Aug 3;12(1):13331. doi: 10.1038/s41598-022-17612-2.
- Kluge L, Bergh C, Einarsson S, Pinborg A, Mikkelsen Englund AL, Thurin-Kjellberg A. Cumulative live birth rates after weight reduction in obese women scheduled for IVF: follow-up of a randomized controlled trial. Hum Reprod Open. 2019 Dec 10;2019(4):hoz030. doi: 10.1093/hropen/hoz030. eCollection 2019.
- Einarsson S, Bergh C, Friberg B, Pinborg A, Klajnbard A, Karlstrom PO, Kluge L, Larsson I, Loft A, Mikkelsen-Englund AL, Stenlof K, Wistrand A, Thurin-Kjellberg A. Weight reduction intervention for obese infertile women prior to IVF: a randomized controlled trial. Hum Reprod. 2017 Aug 1;32(8):1621-1630. doi: 10.1093/humrep/dex235.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
1. oktober 2010
Primær fullføring (Faktiske)
1. januar 2016
Studiet fullført (Faktiske)
1. april 2018
Datoer for studieregistrering
Først innsendt
23. mars 2012
Først innsendt som oppfylte QC-kriteriene
27. mars 2012
Først lagt ut (Anslag)
30. mars 2012
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
7. september 2018
Siste oppdatering sendt inn som oppfylte QC-kriteriene
5. september 2018
Sist bekreftet
1. september 2018
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- Obesity/IVF
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Low calorie diet treatment
-
Optimal Acuity CorporationHar ikke rekruttert ennåTørr aldersrelatert makuladegenerasjon | Synssvikt og blindhet
-
Cairo UniversityRekrutteringOvervekt | Irritabel tarm-syndrom | Abdominal fedmeEgypt
-
Winthrop UniversityRekruttering
-
National Taiwan University HospitalUkjentTykktarmskreft stadium IvTaiwan